Browse studies

Find your next paid study

1 recruiting study matching your filters

An Open Label, Multicenter Study of Nasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis Patients

Only subjects that have completed TILS-021, a Phase 2a Randomized, Double-Blind, Placebo-Controlled, Multicenter Dose-Ranging Study of Nasal Foralumab in Non-A…

Non-Active Secondary Progressive Multiple Sclerosis

Tiziana Life Sciences LTDNCT06890923